215 related articles for article (PubMed ID: 24602482)
1. In vitro efficacy of RiaSTAP after rapid reconstitution.
Karri JV; Cardenas JC; Johansson PI; Matijevic N; Cotton BA; Wade CE; Holcomb JB
J Surg Res; 2014 Aug; 190(2):655-61. PubMed ID: 24602482
[TBL] [Abstract][Full Text] [Related]
2. Stability of Reconstituted Fibrinogen Concentrate in Hemostatic Function and Concentration.
Peng HT; Beckett A
Mil Med; 2021 Feb; 186(3-4):286-292. PubMed ID: 33196820
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
Levy JH; Szlam F; Tanaka KA; Sniecienski RM
Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis.
Whyte CS; Rastogi A; Ferguson E; Donnarumma M; Mutch NJ
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328366
[TBL] [Abstract][Full Text] [Related]
5. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
Elliott BM; Aledort LM
Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma.
Rumph B; Bolliger D; Narang N; Molinaro RJ; Levy JH; Szlam F; Tanaka KA
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):408-12. PubMed ID: 19819728
[TBL] [Abstract][Full Text] [Related]
7. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
Sørensen B; Bevan D
Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
Levy JH; Welsby I; Goodnough LT
Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955
[TBL] [Abstract][Full Text] [Related]
9. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
Yamamoto K
Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
[TBL] [Abstract][Full Text] [Related]
10. Severe pediatric blunt trauma--successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets.
Ziegler B; Schimke C; Marchet P; Stögermüller B; Schöchl H; Solomon C
Clin Appl Thromb Hemost; 2013; 19(4):453-9. PubMed ID: 22964782
[TBL] [Abstract][Full Text] [Related]
11. Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
Triulzi DJ; Blumberg N
Yale J Biol Med; 1990; 63(1):1-7. PubMed ID: 2113328
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro.
Cushing MM; Asmis LM; Harris RM; DeSimone RA; Hill S; Ivascu N; Haas T
Transfusion; 2019 May; 59(5):1818-1826. PubMed ID: 30719724
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.
Galas FR; de Almeida JP; Fukushima JT; Vincent JL; Osawa EA; Zeferino S; Câmara L; Guimarães VA; Jatene MB; Hajjar LA
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1647-55. PubMed ID: 24951020
[TBL] [Abstract][Full Text] [Related]
14. Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial.
Steinmetz J; Sørensen AM; Henriksen HH; Lange T; Larsen CF; Johansson PI; Stensballe J
Trials; 2016 Jul; 17(1):327. PubMed ID: 27430210
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
Morrow GB; Carlier MSA; Dasgupta S; Craigen FB; Mutch NJ; Curry N
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671748
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen recovery and changes in fibrin-based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest.
Lee SH; Lee SM; Kim CS; Cho HS; Lee JH; Lee CH; Kim E; Sung K; Solomon C; Kang J; Kim YR
Transfusion; 2014 May; 54(5):1379-87. PubMed ID: 24192484
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures.
Fenderson JL; Meledeo MA; Rendo MJ; Peltier GC; McIntosh CS; Davis KW; Corley JB; Cap AP
Transfusion; 2019 Apr; 59(S2):1560-1567. PubMed ID: 30980741
[TBL] [Abstract][Full Text] [Related]
19. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.
Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A
J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246
[TBL] [Abstract][Full Text] [Related]
20. Cryoprecipitate-topical thrombin glue. Initial experience in patients undergoing cardiac operations.
Lupinetti FM; Stoney WS; Alford WC; Burrus GR; Glassford DM; Petracek MR; Thomas CS
J Thorac Cardiovasc Surg; 1985 Oct; 90(4):502-5. PubMed ID: 3930885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
